Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression - Wikidata - awgldk - TriplyDB

Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression

Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression

http://www.wikidata.org/entity/Q36128314

about

Ketamine and other glutamate receptor modulators for depression in adults Biological predictors of pharmacological therapy in anxiety disorders Ketamine, sleep, and depression: current status and new questions Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date Rapid Antidepressant Action and Restoration of Excitatory Synaptic Strength After Chronic Stress by Negative Modulators of Alpha5-Containing GABAA Receptors.A Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice.Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder Resting-State Neurophysiological Abnormalities in Posttraumatic Stress Disorder: A Magnetoencephalography Study.Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety.Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics The role of ketamine in treatment-resistant depression: a systematic review.Clinical applications of hallucinogens: A review.Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections.Clinical predictors of ketamine response in treatment-resistant major depression.Ketamine as a promising prototype for a new generation of rapid-acting antidepressants.An excitatory synapse hypothesis of depression Antidepressant-like cognitive and behavioral effects of acute ketamine administration associated with plasticity in the ventral hippocampus to medial prefrontal cortex pathway.Evidence that Subanesthetic Doses of Ketamine Cause Sustained Disruptions of NMDA and AMPA-Mediated Frontoparietal Connectivity in Humans Differential Effects of an NR2B NAM and Ketamine on Synaptic Potentiation and Gamma Synchrony: Relevance to Rapid-Onset Antidepressant Efficacy.Is there anything really novel on the antidepressant horizon?Human biomarkers of rapid antidepressant effects Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression.Connectivity, pharmacology, and computation: toward a mechanistic understanding of neural system dysfunction in schizophrenia.Ketamine as antidepressant? Current state and future perspectives.Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression Ketamine as a fast acting antidepressant: current knowledge and open questions.High-frequency brain activity and muscle artifacts in MEG/EEG: a review and recommendations.EEG biomarkers in major depressive disorder: discriminative power and prediction of treatment response.The use of magnetoencephalography in the study of psychopharmacology (pharmaco-MEG).Translational psychiatry--light at the end of the tunnel.The use of ketamine as an antidepressant: a systematic review and meta-analysis.KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS.Glutamate-Based Drug Discovery for Novel Antidepressants.The organic cation transporter 3 (OCT3) as molecular target of psychotropic drugs: transport characteristics and acute regulation of cloned murine OCT3.Exploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression II: response to antidepressant augmentation strategies.Preliminary differences in resting state MEG functional connectivity pre- and post-ketamine in major depressive disorder.Uncoupling DAPK1 from NMDA receptor GluN2B subunit exerts rapid antidepressant-like effects.Sub-anesthetic ketamine modulates intrinsic BOLD connectivity within the hippocampal-prefrontal circuit in the rat.

P2860

Q24186746-DBC05018-22C4-4B8C-BDF3-6B1FB4E6AF32 Q26781100-BFE5D871-29BE-44E1-9686-20DC971F3122 Q26828564-97A2B13E-FF0A-4DDD-9DB3-0D8B0B5E5D09 Q27004490-89284386-D7E9-42FA-99DC-F07FA213DA56 Q27310950-1EB06AF2-2E0A-44C5-BFEE-98F86E450976 Q30361531-7AC2199D-65AF-46BD-AC44-A7ECEA5C744E Q30711088-E90BC232-2AC5-4566-9DC5-8B13AAB47447 Q33600125-A0982837-6E34-4F30-BFCD-9FB5525876BB Q33874459-C2B5D254-6072-47D7-B797-9539D1B346B6 Q34177760-84F13968-E5B4-4F5D-9C82-9BBDB1A522FA Q34444632-6B597FD5-0548-45DE-BA4C-2F2790D5AEC1 Q34449588-09CF7BAA-6066-41DB-A135-C0ED93F02472 Q34535259-2A6AF130-80FE-4F89-A0F9-B20251409F65 Q34661281-9B549C57-CDF4-4E0C-A751-0BC14EE7B7BC Q35026766-D5CDF2C1-8F85-44E2-8866-E12ADC87D4D0 Q35547495-77BE5A2C-8E81-435C-89C4-1FF995F7D7BD Q35563515-BB9CEFBF-9878-4FBF-ACD3-36691142E400 Q35952277-8A3FDEB1-E3B9-40ED-B92B-98329F6641E0 Q35968145-31C7B1E6-05D1-4CF4-89A2-BD2019619625 Q36798980-02041923-E08C-426A-A478-F76CC7615B5C Q36870889-D6BE6649-FE22-4F85-81D5-4E9CC97B9D9C Q36902074-A5FB2578-52E3-4FB8-815F-A12529246B76 Q37248524-76BE0D97-09BC-4323-823E-90EDB43366B9 Q37405727-3BBDCE11-1561-48F8-9D44-2C376D5090B5 Q37412196-60E2CF49-3BFA-4B2F-BAD5-AB4687AAB684 Q37559823-E0352FAC-AF9F-4FAF-A869-6411F4F127AF Q37712452-B65C0414-EFBE-4C6D-9309-DD5077D53167 Q38098265-266801CB-1261-4644-8FB7-2183B0836096 Q38099831-B5447B93-1FA5-4BD8-82DA-CF762ACD2B0A Q38154919-84FC890D-A509-4436-A713-4ECFB498F5AE Q38219606-60665439-1EC8-4CBF-9240-E606FD17E16C Q38370696-E3F3DB2B-4D4E-4408-A661-B0210C7221E3 Q38408563-37DFC756-CA10-45B0-AA42-73C0F6FEDDD8 Q38803371-EA8854A7-8088-4A34-AB40-594E35145160 Q38895017-8A7476E8-714E-4EF5-859E-4ED07820B45A Q39104258-CB30160E-018C-43B3-BF03-018139A7DC2B Q39333515-A7110AD2-0295-4581-A8BD-2220B84933F9 Q39642484-BFCD1683-87A8-44A5-BAC2-FF83D24AE4CE Q40229544-0CC76FF7-D5B8-4CF9-B901-7F9E2FD9BE2C Q41955383-EE27F017-B18F-45F3-B18F-A60696FC4E8E

P2860

Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression

http://www.wikidata.org/entity/Q36128314

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Synaptic potentiation is criti ...... ent-resistant major depression

@ast

Synaptic potentiation is criti ...... ent-resistant major depression

@en

type

label

Synaptic potentiation is criti ...... ent-resistant major depression

@ast

Synaptic potentiation is criti ...... ent-resistant major depression

@en

prefLabel

Synaptic potentiation is criti ...... ent-resistant major depression

@ast

Synaptic potentiation is criti ...... ent-resistant major depression

@en

P1433

Q36128314-18C50560-1FD8-4BA9-B185-F8B6F1341CC4

P1476

Q36128314-E502D770-616E-4CDE-8A34-A07A998E30AF

P2093

Q36128314-117BD849-302E-4820-9AD0-A6F0DA67B5CE

Q36128314-207C413A-7589-4171-8F95-CBF299C6FD9C

Q36128314-2466B1B0-A59C-4D9A-AB95-B1199866D2B9

Q36128314-62D36EB9-C65D-4A96-B464-D402A31CB544

Q36128314-80869F18-92E3-4E63-9CAA-4335C55B7BE1

Q36128314-BFA0FECC-1D2F-4FC7-84E6-1568000E03FC

Q36128314-EF382E91-45A8-445A-8007-5EEA95A24225

P2860

Q36128314-088BD244-D014-4F71-8F69-055635446D64

Q36128314-0A72EA7B-5DB5-4026-A7F2-A6A413B82BFC

Q36128314-1032FBFA-D13E-4957-8F61-85E4BF8279DA

Q36128314-19197EFA-BB12-40F8-BC61-F0849BB1A8C8

Q36128314-1BBB2A14-FB2D-4AE7-8DB4-2AE02086A4D9

Q36128314-1E0F00AE-FF42-4415-B2CF-0702D9D6A285

Q36128314-1F72C03A-6BAC-4BE1-A556-6A0A87534F0F

Q36128314-27214CAD-6455-4CF4-8EF6-A217FD1F1EB3

Q36128314-295A1316-1DB1-4383-8ADF-42A936ED5647

Q36128314-314A6F06-C8EA-40BB-B0C4-944CC8C4789E

P304

Q36128314-9B05FA9E-3454-43E4-918C-53CD8A5BA64B

P31

Q36128314-87AC4B2D-8F5A-4C48-BAC3-DD79E58405BF

P356

Q36128314-23F7CB24-7C72-4220-8E29-D1F64D894657

P407

Q36128314-8C56C00A-C1C8-469C-9716-56E515C8C95F

P433

Q36128314-58E99C1C-7216-4F5D-AB4B-D23AB25AD992

P478

Q36128314-0525B707-BAB7-49E1-BFCC-A8122A8923B7

P577

Q36128314-07953365-2417-4A04-8F75-0BC74F58181C

P698

Q36128314-BABE60C8-E7B7-41B2-B80B-13E9407BD5EC

P932

Q36128314-5D976B84-3C7C-47D1-83DB-C7F52FC4A87A

P356

J.BIOPSYCH.2012.03.029

P1433

Biological Psychiatry

P1476

Synaptic potentiation is criti ...... ent-resistant major depression

@en

P2093

Brian R Cornwell

http://www.w3.org/2001/XMLSchema#string

Carlos A Zarate

http://www.w3.org/2001/XMLSchema#string

Christian Grillon

http://www.w3.org/2001/XMLSchema#string

Craig A Marquardt

http://www.w3.org/2001/XMLSchema#string

Giacomo Salvadore

http://www.w3.org/2001/XMLSchema#string

Maura Furey

http://www.w3.org/2001/XMLSchema#string

Nancy E Brutsche

http://www.w3.org/2001/XMLSchema#string

P2860

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

Thresholding of statistical maps in functional neuroimaging using the false discovery rate

AFNI: software for analysis and visualization of functional magnetic resonance neuroimages

A new depression scale designed to be sensitive to change

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists

Parvalbumin neurons and gamma rhythms enhance cortical circuit performance

Abnormal neural oscillations and synchrony in schizophrenia

Signal processing in magnetoencephalography.

P304

555-561

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOPSYCH.2012.03.029

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22521148

http://www.w3.org/2001/XMLSchema#string

P932

3408548

http://www.w3.org/2001/XMLSchema#string